Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research center streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The U.K. Medicines and Healthcare Regulatory Agency (MHRA) has green-lighted two separate Phase 3 trials conducted by Compass Pathways (NASDAQ: CMPS) for Treatment-Resistant Depression and Awakn Life Sciences (OTCMKTS: AWKNF) for Severe Alcohol Use Disorder (SAUD).
A racial justice advocacy organization has reportedly overspent on executive salaries and some projects that had doubtful effects on the nonprofit s actual advocacy. The organization has also been
I went to the world’s largest psychedelic conference a few weeks ago Psychedelic Science the one where Jaden Smith told a crowd of some 11,000 psychonauts and scientists that his mum (Jada Pinkett Smith) recently introduced the family to psychedelics. Why was Jaden Smith being interviewed at a scientific conference? I honestly have no idea but the delightful wackiness of this industry is one of the main reasons I love reporting on it.